Document:

EX-10.2

 Exhibit 10.2 

INDEMNIFICATION AGREEMENT 

This INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into effective as of the     day of
        2013 by and between Pure Bioscience, Inc., a Delaware corporation (the “Company”), and
                    (the “Indemnitee”). 

WHEREAS, the Company believes it is essential to retain and attract qualified directors and officers; 

WHEREAS, the Indemnitee is a director and/or officer of the Company; 

WHEREAS, both the Company and the Indemnitee recognize the increased risk of litigation and other claims being asserted against directors and
officers of public companies; 
 WHEREAS, the (i) Company’s Certificate of Incorporation (the “Certificate of
Incorporation”) provides that, to the fullest extent permitted by Delaware statutory or decisional law, no director of the Company shall be personally liable to the Company or its stockholders for breach of fiduciary duty as a director and
(ii) the Company’s Bylaws (the “Bylaws”) require the Company to indemnify its directors and officers to the greatest extent permitted by the DGCL (as hereinafter defined) and permits the Company to advance expenses in
connection therewith; 
 WHEREAS, the Indemnitee has been serving and intends to continue serving as a director and/or officer of the
Company in part in reliance on the Certificate of Incorporation and Bylaws; and 
 WHEREAS, in recognition of the Indemnitee’s need for
(i) substantial protection against personal liability based on the Indemnitee’s reliance on the Certificate of Incorporation and Bylaws, (ii) specific contractual assurance that the protection promised by the Certificate of
Incorporation and Bylaws will be available to the Indemnitee, regardless of, among other things, any amendment to or revocation of the Bylaws or any change in the composition of the Company’s Board of Directors (the “Board”) or
acquisition transaction relating to the Company, and (iii) an inducement to continue to provide effective services to the Company as a director and/or officer thereof, the Company wishes to provide for the indemnification of the Indemnitee and
to advance expenses to the Indemnitee to the fullest extent permitted by law and as set forth in this Agreement, and to provide for the continued coverage of the Indemnitee under the Company’s directors’ and officers’ liability
insurance policies. 
 NOW, THEREFORE, in consideration of the premises contained herein and of the Indemnitee continuing to serve the
Company directly or, at its request, with another enterprise, and intending to be legally bound hereby, the parties hereto agree as follows: 
  

	1.	Certain Definitions. 

 (a) “Change in Control” shall mean the occurrence
of any of the following events: (i) the closing of the sale, transfer or other disposition of all or substantially all of the Company’s assets or the exclusive license of substantially all of the intellectual property of the Company
material to the business of the Company resulting in the Company being unable to continue its business as in effect prior to such license; provided, however, that a mortgage, 

  
 1 

 
pledge or grant of a security interest to a bona fide lender shall not by itself constitute a Change of Control; (ii) the consummation of a merger or consolidation of the Company with or
into another entity in which the stockholders of the Company exchange their shares of capital stock of the Company for cash, stock, property or other consideration (except one in which the stockholders of the Company as constituted immediately prior
to such transaction continue to hold after the transaction at least 50% of the voting power of the capital stock of the Company or the surviving or acquiring entity or parent entity of the surviving or acquiring entity); (iii) any
“person,” as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the “Exchange Act”) (other than (a) a trustee or other fiduciary
holding securities under an employee benefit plan of the Company, (b) a corporation owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company or
(c) any current beneficial stockholder or group, as defined by Rule 13d-5 of the Exchange Act, including the heirs, assigns and successors thereof, of beneficial ownership, within the meaning of Rule 13d 3 of the Exchange Act, of securities
possessing more than 20% of the total combined voting power of the Company’s outstanding securities) hereafter becomes the “beneficial owner,” as defined in Rule 13d 3 of the Exchange Act, directly or indirectly, of securities of the
Company representing 35% or more of the total combined voting power represented by the Company’s then outstanding voting securities; or (iv) individuals who, as of sixty (60) days after the Effective Date of this Agreement are members
of the Board (the “Incumbent Board”) cease for any reason to constitute at least a majority of the members of the Board; provided, however, that if the appointment or election (or nomination for election) of any new Board member was
approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Agreement, be considered as a member of the Incumbent Board; provided further, however, that a
transaction under clauses (ii) or (iii) above shall not constitute a Change of Control: (A) if its primary purpose is to change the state of the Company’s incorporation, (B) if its primary purpose is to create a holding
company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately prior to such transaction, or (C) if it is a bona fide equity financing in which the Company is the surviving
corporation. 
 (b) “DGCL” shall mean the General Corporation Law of the State of Delaware, as the same exists or may
hereafter be amended or interpreted; provided, however, that in the case of any such amendment or interpretation, only to the extent that such amendment or interpretation permits the Company to provide broader indemnification rights than were
permitted prior thereto. 
 (c) “Expense” shall mean costs, expenses, liabilities and losses (including, without
limitation, attorneys’ fees, judgments, fines, penalties, ERISA excise taxes, penalties and amounts paid in settlement and all other costs, expenses and obligations paid or incurred in connection with investigating, defending, being a witness
in or participating in (including on appeal), or preparing for any of the foregoing, any Proceeding relating to any Indemnifiable Event. 

(d) “Indemnifiable Event” shall mean any event or occurrence that takes place either prior to or after the execution of this
Agreement, related to the Company. 

  
 2 

 (e) “Proceeding” shall mean any threatened, pending or completed action, suit,
investigation or proceeding, and any appeal thereof, whether civil, criminal, administrative or investigative, and/or any inquiry or investigation (whether conducted by the Company or any other party, that the Indemnitee in good faith believes might
lead to the institution of such action) in which Indemnitee is made, or is threatened to be made, a party to, or a witness in, such action, suit, proceeding or investigation by reason of the fact that Indemnitee is or was an officer, director or
employee of the Company or is or was serving as an officer, director, member, employee, trustee or agent of any other entity at the request of Company. 

(f) “Reviewing Party” shall mean any appropriate person or body consisting of a member or members of the Company’s Board
or any other person or body appointed by the Board (including the special independent counsel referred to in Section 6) who is not a party to the particular Proceeding with respect to which the Indemnitee is seeking indemnification. 

(g) “Voting Securities” shall mean any securities of the Company which vote generally in the election of directors. 

2. Indemnification. In the event the Indemnitee was or is a party to or is involved (as a party, witness, or otherwise) in any Proceeding by reason of
(or arising in part out of) an Indemnifiable Event, whether the basis of the Proceeding is the Indemnitee’s alleged action in an official capacity as a director or officer or in any other capacity whether or not while serving as a director or
officer, the Company shall indemnify the Indemnitee to the fullest extent permitted by the DGCL against any and all Expenses, liability, and loss (including, but not limited to, judgments, fines, ERISA excise taxes or penalties, and amounts paid or
to be paid in settlement, and any interest, assessments, or other charges imposed thereon, and any federal, state, local, or foreign taxes imposed on any director or officer as a result of the actual or deemed receipt of any payments under this
Agreement) (collectively, “Liabilities”) reasonably incurred or suffered by such person in connection with such Proceeding. The Company shall provide indemnification pursuant to this Section 2 as soon as practicable, but in no
event later than 20 days after it receives written demand from the Indemnitee. Notwithstanding anything in this Agreement to the contrary and except as provided in Section 5 below, the Indemnitee shall not be entitled to indemnification
pursuant to this Agreement (i) in connection with any Proceeding initiated by the Indemnitee against the Company or any director or officer of the Company unless the Company has joined in or consented to the initiation of such Proceeding or
(ii) on account of any suit in which judgment is rendered against the Indemnitee pursuant to Section 16(b) of the Exchange Act for an accounting of profits made from the purchase or sale by the Indemnitee of securities of the Company. The
Company shall indemnify the Indemnitee to the fiullest extent permitted by the Company’s Bylaws and applicable Delaware law. 
 3. Advancement of
Expenses. The Company shall advance Expenses to the Indemnitee within 10 business days of such request (an “Expense Advance”); provided, however, that if required by the DCGL, such Expenses shall be advanced only upon delivery
to the Company of written acknowledgment by or on behalf of the Indemnitee to repay such amount if it is ultimately determined by a court of competent jurisdiction (including the resolution of such matter on appeal) that the Indemnitee is not
entitled to be indemnified by the Company; and provided further, that the Company shall make such advances only to the extent permitted by law. Expenses incurred by the Indemnitee while not acting in his/her capacity as a director or officer,
including service with respect to employee benefit plans, may be advanced upon such terms and conditions as the Board, in its sole discretion, deems appropriate. 

  
 3 

 4. Review Procedure for Indemnification. Notwithstanding the foregoing, (i) the obligations of the
Company under Sections 2 and 3 above shall be subject to the condition that the Reviewing Party shall not have determined (in a written opinion, in any case in which the special independent counsel referred to in Section 6 hereof is involved)
that the Indemnitee would not be permitted to be indemnified under applicable law, and (ii) the obligation of the Company to make an Expense Advance pursuant to Section 3 above shall be subject to the condition that, if, when and to the
extent that the Reviewing Party determines that the Indemnitee would not be permitted to be so indemnified under applicable law, the Company shall be entitled to be reimbursed by the Indemnitee (who hereby agrees to reimburse the Company) for all
such amounts theretofore paid; provided, however, that if the Indemnitee has commenced legal proceedings in a court of competent jurisdiction pursuant to Section 5 below to secure a determination that the Indemnitee should be indemnified under
applicable law, any determination made by the Reviewing Party that the Indemnitee would not be permitted to be indemnified under applicable law shall not be binding and the Indemnitee shall not be required to reimburse the Company for any Expense
Advance until a final judicial determination is made with respect thereto (as to which all rights of appeal therefrom have been exhausted or have lapsed). The Indemnitee’s obligation to reimburse the Company for Expense Advances pursuant to
this Section 4 shall be unsecured and no interest shall be charged thereon. The Reviewing Party shall be selected by the Board, unless there has been a Change in Control, other than a Change in Control which has been approved by a majority of
the Company’s Board who were directors immediately prior to such Change in Control, in which case the Reviewing Party shall be the special independent counsel referred to in Section 6 hereof. 

5. Enforcement of Indemnification Rights. If the Reviewing Party determines that the Indemnitee substantively would not be permitted to be indemnified
in whole or in part under applicable law, or if the Indemnitee has not otherwise been paid in full pursuant to Sections 2 and 3 above within 10 days after a written demand has been received by the Company, the Indemnitee shall have the right to
commence litigation in any court in the State of California or Delaware having subject matter jurisdiction thereof and in which venue is proper to recover the unpaid amount of the demand (an “Enforcement Proceeding”) and, if
successful in whole or in part, the Indemnitee shall be entitled to be paid any and all Expenses in connection with such Enforcement Proceeding. The Company hereby consents to service of process for such Enforcement Proceeding and to appear in any
such Enforcement Proceeding. Any determination by the Reviewing Party otherwise shall be conclusive and binding on the Company and the Indemnitee. 
 6.
Change in Control. The Company agrees that if there is a Change in Control of the Company, other than a Change in Control which has been approved by a majority of the Company’s Board who were directors immediately prior to such Change in
Control, then with respect to all matters thereafter arising concerning the rights of the Indemnitee to indemnity payments and Expense Advances under this Agreement or any other agreement or under applicable law or the Company’s Certificate of
Incorporation or Bylaws now or hereafter in effect relating to indemnification for Indemnifiable Events, the Company shall seek legal advice only from special independent counsel selected by the Indemnitee and approved by the

  
 4 

 
Company, which approval shall not be unreasonably withheld. Such special independent counsel shall not have otherwise performed services for the Company or the Indemnitee, other than in
connection with such matters, within the last five years. Such independent counsel shall not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the
Company or the Indemnitee in an action to determine the Indemnitee’s rights under this Agreement. Such counsel, among other things, shall render its written opinion to the Company and the Indemnitee as to whether and to what extent the
Indemnitee would be permitted to be indemnified under applicable law. The Company agrees to pay the reasonable fees of the special independent counsel referred to above and to indemnify fully such counsel against any and all expenses (including
attorneys’ fees), claims, liabilities and damages arising out of or relating to this Agreement or the engagement of special independent counsel pursuant to this Agreement. 

7. Partial Indemnity. If the Indemnitee is entitled under any provision of this Agreement to indemnification by the Company for some or a portion of
the Expenses and Liabilities, but not, however, for the entire amount thereof, the Company shall nevertheless indemnify the Indemnitee for the portion thereof to which the Indemnitee is entitled. Moreover, notwithstanding any other provision of this
Agreement, to the extent that the Indemnitee has been successful on the merits or otherwise in defense of any or all Proceedings relating in whole or in part to an Indemnifiable Event or in defense of any issue or matter therein, including dismissal
without prejudice, the Indemnitee shall be indemnified against all Expenses incurred in connection therewith. In connection with any determination by the Reviewing Party or otherwise as to whether the Indemnitee is entitled to be indemnified
hereunder, the burden of proof shall be on the Company to establish that the Indemnitee is not so entitled. 
 8. Non-exclusivity. The rights of the
Indemnitee hereunder shall be in addition to any other rights the Indemnitee may have under any statute, provision of the Company’s Certificate of Incorporation or Bylaws, vote of stockholders or disinterested directors or otherwise, both as to
action in an official capacity and as to action in another capacity while holding such office. To the extent that a change in the DGCL permits greater indemnification by agreement than would be afforded currently under the Company’s Certificate
of Incorporation and Bylaws and this Agreement, it is the intent of the parties hereto that the Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change without further need to amend this Agreement. 

9. Liability Insurance. The Company shall be obligated to maintain an insurance policy or policies providing directors’ and officers’
liability insurance, and the Indemnitee shall be covered by such policy or policies, in accordance with its or their terms, to the maximum extent of the coverage determined by the Board. 

10. Settlement of Claims. The Company shall not be liable to indemnify the Indemnitee under this Agreement (a) for any amounts paid in settlement
of any action or claim effected without the Company’s written consent, which consent shall not be unreasonably withheld; or (b) for any judicial award if the Company was not given a reasonable and timely opportunity, at its expense, to
participate in the defense of such action. 
 11. No Presumption. For purposes of this Agreement, to the fullest extent permitted by law, the
termination of any Proceeding, action, suit or claim, by judgment, order, settlement (whether 

  
 5 

 
with or without court approval) or conviction, or upon a plea of nolo contendere, or its equivalent, shall not create a presumption that the Indemnitee did not meet any particular standard of
conduct or have any particular belief or that a court has determined that indemnification is not permitted by applicable law. 
 12. Period of
Limitations. No legal action shall be brought and no cause of action shall be asserted by or on behalf of the Company or any affiliate of the Company against the Indemnitee, the Indemnitee’s spouse, heirs, executors or personal or legal
representatives after the expiration of two years from the date of accrual of such cause of action, or such longer period as may be required by state law under the circumstances, and any claim or cause of action of the Company or its affiliate shall
be extinguished and deemed released unless asserted by the timely filing of a legal action within such period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action, such shorter period
shall govern. 
 13. Consent and Waiver by Third Parties. The Indemnitee hereby represents and warrants that he or she has obtained all
waivers and/or consents from third parties which are necessary for his or her employment with the Company on the terms and conditions set forth herein and to execute and perform this Agreement without being in conflict with any other agreement,
obligation or understanding with any such third party. The Indemnitee represents that he or she is not bound by any agreement or any other existing or previous business relationship which conflicts with, or may conflict with, the performance of his
or her obligations hereunder or prevent the full performance of his or her duties and obligations hereunder. 
 14. Amendment of this
Agreement. No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of
any other provisions hereof (whether or not similar), nor shall such waiver constitute a continuing waiver. Except as specifically provided herein, no failure to exercise or any delay in exercising any right or remedy hereunder shall constitute a
waiver thereof. 
 15. Primacy of Indemnification. Notwithstanding that the Indemnitee may have certain rights to indemnification,
advancement of expenses and/or insurance provided by other persons (collectively, the “Other Indemnitors”), the Company: (i) shall be the indemnitor of first resort (i.e., its obligations to the Indemnitee are primary and any
obligation of the Other Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by the Indemnitee are secondary); and (ii) shall be required to advance the full amount of Expenses incurred by
the Indemnitee and shall be liable for the full amount of all Expenses, without regard to any rights the Indemnitee may have against any of the Other Indemnitors. No advancement or payment by the Other Indemnitors on behalf of the Indemnitee with
respect to any claim for which the Indemnitee has sought indemnification from the Company shall affect the immediately preceding sentence, and the Other Indemnitors shall have a right of contribution and/or be subrogated to the extent of such
advancement or payment to all of the rights of recovery of the Indemnitee against the Company. The Company and the Indemnitee agree that the Other Indemnitors are express third party beneficiaries of the terms of this Section 15. 

16. Subrogation. In the event of payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the
rights of recovery of the Indemnitee (other  

  
 6 

 
than against the Other Indemnitors), who shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary
to enable the Company effectively to bring suit to enforce such rights. 
 17. No Duplication of Payments. Except as otherwise set forth in
Section 15 above, the Company shall not be liable under this Agreement to make any payment in connection with any claim made against Indemnitee to the extent the Indemnitee has otherwise actually received payment (under any insurance policy,
Bylaw, vote, agreement or otherwise) of the amounts otherwise indemnifiable hereunder. 
 18. Binding Effect. This Agreement shall be
binding upon and inure to the benefit of and be enforceable by the parties hereto and their respective successors, assigns, including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the
business and/or assets of the Company, spouses, heirs, and personal and legal representatives. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all,
or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to the Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that
the Company would be required to perform if no such succession had taken place. This Agreement shall continue in effect regardless of whether the Indemnitee continues to serve as a director or officer of the Company or of any other enterprise at the
Company’s request. 
 19. Severability. The provisions of this Agreement shall be severable in the event that any of the
provisions hereof (including any provision within a single section, paragraph or sentence) is held by a court of competent jurisdiction to be invalid, void or otherwise unenforceable, and the remaining provisions shall remain enforceable to the
fullest extent permitted by law. Furthermore, to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of this Agreement containing any provision held to be invalid, void or otherwise
unenforceable, that is not itself invalid, void or unenforceable) shall be construed so as to give effect to the intent manifested by the provision held invalid, illegal or unenforceable. 

20. Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware, without
giving effect to the principles of conflicts of laws. 
 21. Counterparts. This Agreement may be executed in one or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 22. Notices. All
notices, demands, and other communications required or permitted hereunder shall be made in writing and shall be deemed to have been duly given if delivered by hand, against receipt, or mailed, postage prepaid, certified or registered mail, return
receipt requested, and addressed to the Company at: 
  

					
		 	Pure Bioscience, Inc.	 	
		 	1725 Gillespie Way	 	
		 	El Cajon, California 92020	 	
		 	Attention: Chief Operating Officer	 	

  
 7 

					
	 and to the Indemnitee at:
	 		 	
		 	                                     
       	 	
		 	                                     
       	 	
		 	                                     
       	 	
		 	                                     
       	 	

 Notice of change of address shall be effective only when done in accordance with this Section. All notices
complying with this Section shall be deemed to have been received on the date of delivery or on the third business day after mailing. 

[Remainder of Page Intentionally Left Blank] 

  
 8 

 IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of the
day first set forth above. 
  

			
	THE COMPANY:
	
	PURE BIOSCIENCE, INC.
		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

 

			
	INDEMNITEE:
	
	  

	Signature
		
	Print Name:	 	  

  
 9EX-10.32

 Exhibit 10.32 

PURE BIOSCIENCE, INC. 

September 17, 2013 
 Mr. Gary Cohee 

Via E-Mail 
 Re: Board of
Directors Letter Agreement 
 Dear Gary: 

While you have already accepted appointment to the Board of Directors (the “Board”) of PURE Bioscience, Inc. (“PURE” or the
“Company”) effective the 13th day of August 2013, it is in the best interests of you and PURE that there be a clear understanding of the terms and conditions related to your service as a
member of the Board. Upon execution below, this letter agreement shall constitute a binding agreement between you and the Company (the “Agreement”) and will contain all of the terms and conditions relating to the services you are to
provide. 
 NOW, THEREFORE, in consideration of the promises and the mutual covenants contained herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties, intending to be legally bound, hereby agree as follows: 

Start Date: August 13, 2013 (the “Effective Date”) shall constitute your starting date. You will serve as a
member of the Board until the annual meeting for the year in which your term expires or until your successor has been elected and qualified, subject however, to your prior death, resignation, retirement, disqualification, or removal from office.

 Term: Your initial term shall be one (1) year. 

Services: You shall render services as a member of the Board (hereinafter, your “Duties”). During the Term of
this Agreement, you shall attend and participate in such number of meetings of the Board as regularly or specially called, but in any case no fewer than four (4) meetings per year. You may attend and participate in each such meeting via
teleconference, videoconference, or in person. You shall consult with other members of the Board regularly and as necessary via telephone, electronic mail, or other forms of correspondence. You shall also participate in approximately
twelve (12) conference calls for operational purposes with the Company’s management in any year. 
 Committees: You
acknowledge and agree that in order to satisfy certain rules for public companies you may be required to serve on one or more of the Board’s Audit Committee, Compensation Committee, and/or Nominating and Governance Committee, and that such
committee assignments will be agreed between you and the Company, and that you will be compensated for service on any committee as provided herein. 

Compensation: In consideration of your services as a member of the Board, upon execution of this Agreement the Company will
issue to you restricted stock units to acquire two hundred fifty thousand (250,000) shares of Company common stock (the “Units”) pursuant to the Restricted Stock Unit Agreement attached hereto as Exhibit “A”. As a member of
the Board, you will receive an annual Board retainer fee of Sixty Thousand Dollars ($60,000) per year for your Services (the “Annual Retainer”). This Annual Retainer shall be payable in quarterly cash increments of Fifteen Thousand

 Mr. Gary Cohee; Board of Directors Letter Agreement 

September 17, 2013 
  Page
 2
 
  

 
Dollars ($15,000). Further, should the Company, through your efforts, either be introduced to or assisted in obtaining grant and/or other funding opportunities, you would be paid a bonus of the
total grant and/or funding in an amount to be determined by the Board in its sole and absolute discretion. 
 Expenses: The
Company agrees to reimburse all of your travel and other reasonable documented expenses relating to your attendance at meetings of the Board. In addition, the Company agrees to reimburse you for reasonable expenses that you incur in connection
with the performance of your duties as a director of the Company. 
 Indemnification: You will receive indemnification as a
director of the Company to the maximum extent extended to directors of the Company generally, as set forth in the Company’s Certificate of Incorporation, Bylaws, and the Indemnification Agreement to be executed by you and the Company, a copy of
which is attached hereto as Exhibit “B”. 
 D&O Insurance: During and throughout the Term the Company shall
include you as an insured under an officers and directors insurance policy providing for coverage no less than provided under the current policy. 

Service For Others: You will be free to represent or perform services for other persons during the Term. However, you agree
that you do not presently perform and do not intend to perform, during the Term, similar Duties, consulting, or other services for companies whose businesses are or would be, in any way, competitive with the Company (except for companies previously
disclosed by you to the Company in writing). Should you propose to perform similar Duties, consulting, or other services for any such company, you agree to notify the Company in writing in advance (specifying the name of the organization for
whom you propose to perform such services) and to provide information to the Company sufficient to allow it to determine if the performance of such services would conflict with areas of interest to the Company. 

No Assignment: Because of the personal nature of the services to be rendered by you, this Agreement may not be assigned by you
without the prior written consent of the Company.
 Confidential Information: In consideration of your access to the premises
of the Company and/or you access to certain Confidential Information of the Company, in connection with your business relationship with the Company, you hereby represent and agree as follows: 

Definition: For purposes of this Agreement the term “Confidential Information” means: 

i. Any information which the Company possesses that has been created, discovered, or developed by or for the Company, and which has or
could have commercial value or utility in the business in which the Company is engaged; or 
 ii. Any information that is related to
the business of the Company and is generally not known by non-Company personnel. 
 iii. By way of illustration, but not limitation,
Confidential Information includes trade secrets and any information concerning products, processes, formulas, designs, inventions (whether or not patentable or registrable under copyright or similar laws, and whether or not

 Mr. Gary Cohee; Board of Directors Letter Agreement 

September 17, 2013 
  Page
 3
 
  

 
reduced to practice), discoveries, concepts, ideas, improvements, techniques, methods, research, development and test results, specifications, data, know-how, software, formats, marketing plans,
and analyses, business plans and analyses, strategies, forecasts, customer and supplier identities, characteristics and agreements. 

Exclusions: Notwithstanding the foregoing, the term Confidential Information shall not include: 

i. Any information which becomes generally available to the public other than as a result of a breach of the confidentiality portions
of this Agreement, or any other agreement requiring confidentiality between the Company and you; 
 ii. Information received from a
third party in rightful possession of such information who is not restricted from disclosing such information; and 
 iii.
Information known by you prior to receipt of such information from the Company, which prior knowledge can be documented. 

Documents: You agree that, without the express written consent of the Company, you will not remove from the Company’s
premises, any notes, formulas, programs, data, records, machines or any other documents or items which in any manner contain or constitute Confidential Information, nor will you make reproductions or copies of same. In the event you receive any
such documents or items by personal delivery from any duly designated or authorized personnel of the Company, you shall be deemed to have received the express written consent of the Company. In the event that you receive any such documents or
items, other than through personal delivery as described in the preceding sentence, you agree to inform the Company promptly of your possession of such documents or items. You shall promptly return any such documents or items, along with any
reproductions or copies to the Company upon the Company’s demand, upon termination of this Agreement, or upon your termination or Resignation, as defined herein. 

No Disclosure: You agree that you will hold in trust and confidence all Confidential Information and will not disclose to
others, directly or indirectly, any Confidential Information or anything relating to such information without the prior written consent of the Company, except as maybe necessary in the course of your business relationship with the Company. You
further agree that you will not use any Confidential Information without the prior written consent of the Company, except as may be necessary in the course of your business relationship with the Company, and that the provisions of this paragraph
shall survive termination of this Agreement. 
 Termination and Resignation: Your membership on the Company’s Board may
be terminated for any or no reason at a meeting called for the purpose of the election of directors by a vote of the stockholders holding at least a majority of the shares of the Company’s issued and outstanding shares entitled to vote. Your
membership on a Board committee may be terminated for any or no reason at any meeting of the Board by or by written consent of, a majority of the Board at any time. You may also terminate your membership on the Board or on a committee for any or no
reason by delivering your written notice of resignation to the Company (“Resignation”), and such Resignation shall be effective upon the time specified therein or, if no time is specified, upon receipt of the notice of resignation by the
Company. Upon the effective date of the termination or Resignation, your right to 

 Mr. Gary Cohee; Board of Directors Letter Agreement 

, 2013 
  Page
 4
 
  

 
compensation hereunder will terminate subject to the Company’s obligations to pay you any cash compensation that you have already earned and to reimburse you for approved expenses already
incurred in connection with your performance of your Duties as of the effective date of such termination or Resignation. 
 Governing
Law: All questions with respect to the construction and/or enforcement of this Agreement, and the rights and obligations of the parties hereunder, shall be determined in accordance with the law of the State of California applicable to
agreements made and to be performed entirely in the State of California, without giving effect to any choice or conflict of law provision or rule (whether of the State of California or any other jurisdiction) that would cause the application of the
laws of any jurisdiction other than the State of California. If any court action is necessary to enforce the terms and conditions of this Agreement, the Parties hereby agree that the Superior Court of California, County of San Diego (El Cajon),
shall be the sole jurisdiction and venue for the bringing of such action. 
 Entire Agreement; Amendment; Waiver; Counterparts:
This Agreement and all references herein expresses the entire understanding with respect to the subject matter hereof and supersedes and terminates any prior oral or written agreements with respect to the subject matter hereof. Any term of
this Agreement may be amended and observance of any term of this Agreement may be waived only with the written consent of the parties hereto. Waiver of any term or condition of this Agreement by any party shall not be construed as a waiver of
any subsequent breach or failure of the same term or condition or waiver of any other term or condition of this Agreement. The failure of any party at any time to require performance by any other party of any provision of this Agreement shall
not affect the right of any such party to require future performance of such provision or any other provision of Agreement. This Agreement may be executed in any number of counterparts, all of which when taken together shall be considered one
and the same agreement, it being understood that all Parties need not sign the same counterpart. In the event that any signature is delivered by fax or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid
and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 

Provision Not Construed Against Party Drafting Agreement. This Agreement is the result of negotiations by and between the
parties, and each party has had the opportunity to be represented by independent legal counsel of its choice. This Agreement is the product of the work and efforts of all parties, and shall be deemed to have been drafted by all parties. In the event
of a dispute, no party hereto shall be entitled to claim that any provision should be construed against any other party by reason of the fact that it was drafted by one particular party. 

No Employment: Nothing contained in this Agreement should be construed as an offer of employment or as creating an
employment relationship. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 Mr. Gary Cohee; Board of Directors Letter Agreement 

September 17, 2013 
  Page
 5
 
  

 If the foregoing terms are agreeable, please indicate your acceptance by signing in the space
provided below and returning this Agreement to the Company. By executing this Agreement below you further represent and warrant that you are not subject to any agreement, commitment, contract (written or oral) or other instrument which would be
breached by executing this Agreement. 
  

			
	 Very truly yours;
  

PURE BIOSCIENCE, INC.

		
	BY:  	 	/s/ Henry R. Lambert
		 	HENRY R. LAMBERT, CEO

 Accepted and Agreed: 
  

							
				
		  	Signature:	  	/s/ Gary Cohee	  	
				
		  	Name:	  	Gary Cohee	  	
				
		  	Date:	  	September 17, 2013

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00222-of-00352.parquet"}]]